Lukas Biomedical Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma (NCT05304481) | Lukas Biomedical Inc. | 2022-05-14 |
Track Lukas Biomedical Inc. automatically
Every clearance here is in the API, with alerts when new ones post.